Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
11.60
+0.84 (7.81%)
Feb 6, 2026, 4:00 PM EST - Market closed
Biohaven Market Cap
Biohaven has a market cap or net worth of $1.54 billion as of February 6, 2026. Its market cap has decreased by -62.61% in one year.
Market Cap
1.54B
Enterprise Value
1.59B
1-Year Change
-62.61%
Ranking
Category
Stock Price
$11.60
Market Cap Chart
Since September 23, 2022, Biohaven's market cap has increased from $261.58M to $1.54B, an increase of 488.42%. That is a compound annual growth rate of 69.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 1.54B | 2.75% |
| Dec 31, 2025 | 1.50B | -60.34% |
| Dec 31, 2024 | 3.78B | 9.99% |
| Dec 29, 2023 | 3.43B | 262.97% |
| Dec 30, 2022 | 946.07M | 261.68% |
| Sep 23, 2022 | 261.58M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innoviva | 1.63B |
| Immunocore Holdings | 1.62B |
| Sionna Therapeutics | 1.62B |
| Oruka Therapeutics | 1.60B |
| uniQure | 1.60B |
| Celldex Therapeutics | 1.58B |
| Monte Rosa Therapeutics | 1.55B |
| Agios Pharmaceuticals | 1.55B |